V

Vitae Research Center | Miami, FL

Research site

(Unclaimed)

Location

330 SW 27th Avenue Suite 502, Miami, Florida, United States of America

Site insights

Top conditions

Top treatments

Omalizumab

Lecanemab

AR1001

Clobetasol Propionate

BPN14770

TRx0237

Piromelatine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 10 total trials

A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease (Clarity AD)

This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...

Active, not recruiting

Early Alzheimer's Disease

Drug: Lecanemab SC

Drug: Lecanemab IV

Phase 3, Double-blind, Randomized, Placebo-controlled Trial to Evaluate the Efficacy and Safety of AR1001 in Participants With Early Alzheimer's Disease (Polaris-AD)

This AR1001-ADP3-US01 protocol is a double-blind, randomized, placebo-controlled, multi- center, parallel-group comparison pivotal Phase 3 study to e...

Active, not recruiting

Alzheimer Disease

Drug: Placebo

Drug: AR1001

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are...

Active, not recruiting

Alzheimer's Disease

Drug: Piromelatine 20 mg

Drug: Placebo